Gareth joined Polar Capital in 2007 to set up the Healthcare team. Prior to this, he worked at Framlington, where he began his career in investment management in 1999. Soon afterwards, he began working on the Framlington Health Fund and in 2004 became manager of the Framlington Biotech Fund which he managed from 2004 until his departure. Gareth studied biochemistry, during which time he worked at Yamanouchi, a leading Japanese pharmaceutical company (later to become Astellas). As well as this, Gareth worked for the Oxford Business School and various academic laboratories including the Sir William Dunn School of Pathology and the Wolfson Institute for Biomedical Research.